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Nonstandard Abbreviations and Acronyms: 
 
  
ACTA2           smooth muscle α actin 
ADSCs adipose tissue-derived mesenchymal stem cells 
αMEM minimal essential medium 
CNN1 calponin 
Crat                 carnitine acetyltransferase 
DAPI               4′,6-diamidino-2-phenylindole 
ECAR              extracellular acidification rate 
ECs endothelial cells 
FABP4 fatty acid binding protein 4 
FCCP  carbonyl cyanide-p-trifluoromethoxyphenylhydrazone 
GC-MS            gas chromatography-mass spectrometry 
MCP1              monocyte chemoattractant protein 1 
GO gene ontology 
MDS                multi-dimensional scaling analysis 
miR                 microRNA 
MSC                mesenchymal stem/stromal cells 
NMR nuclear magnetic resonance 
OCR                oxygen consumption rate 
OPN osteopontin 
PPARg            peroxisome proliferator-activated receptor-γ 
PV-ADSCs      perivascular adipose tissue-derived mesenchymal stem cells 
PVAT              perivascular adipose tissue 
Q-PCR quantitativ -polymerase chain reaction 
RFP                 red fluorescent protein 
Sca1 stem cell antigen 1 
scRNA-seq single-cell RNA-sequencing 
SMCs              smooth muscle cells 
SRC spare respiratory capacity 
TAGLN smooth muscle protein 22-alpha 
TCA cycle tricarboxylic acid cycle 
TGFb1 transforming growth factor β 1 
TMRM Tetramethylrhodamine, Methyl ester, Perchlorate 
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Abstract 
Objective—Perivascular adipose tissue (PVAT) plays a vital role in maintaining vascular homeostasis. 
However, most studies ascribed the function of PVAT in vascular remodeling to adipokines secreted 
by the perivascular adipocytes. Whether mesenchymal stem cells (MSCs) exist in PVAT and play a 
role in vascular regeneration remain unknown.   
Approach and Results—Single-cell RNA-sequencing (scRNA-seq) allowed direct visualization of the 
heterogeneous perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs) at a high 
resolution and revealed two distinct sub-populations, among which one featured signaling pathways 
crucial for smooth muscle differentiation. Pseudotime analysis of cultured PV-ADSCs unraveled their 
smooth muscle differentiation trajectory. Transplantation of cultured PV-ADSCs in mouse vein graft 
model suggested the contribution of PV-ADSCs to vascular remodeling through smooth muscle 
differentiation. Mechanistically, treatment with TGFb1 and transfection of miR-378a-3p mimics 
induced a similar metabolic reprogramming of PV-ADSCs, including upregulated mitochondrial 
potential and altered lipid levels such as increased cholesterol and promoted smooth muscle 
differentiation.  
Conclusions—ScRNA-seq allows direct visualization of PV-ADSC heterogeneity at a single-cell 
level and uncovers two sub-populations with distinct signature genes and signaling pathways. The 
function of PVAT in vascular regeneration are partly attributed to PV-ADSCs and their differentiation 
towards smooth muscle lineage. Mechanistic study presents miR-378a-3p which is a potent regulator 
of metabolic reprogramming as a potential therapeutic target for vascular regeneration.  
 
Keywords: Perivascular adipose tissue, stem cells, single-cell RNA-sequencing, smooth muscle 
differentiation, vascular remodeling, metabolic reprogramming  
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Introduction 
Perivascular adipose tissue (PVAT) anatomically abuts the adventitial side of the artery.1 Changes in 
the phenotype of PVAT correlates with disease progression such as atherosclerosis, and the increase 
of volume and upregulation of inflammatory factors secreted by adipocytes are associated with worse 
outcomes.2 Loss of PVAT resulting from the specific deletion of peroxisome proliferator-activated 
receptor-γ (PPARg) in murine smooth muscle cells (SMCs) contributes to endothelial dysfunction and 
impairs vascular homeostasis.3 Moreover, transplantation of PVAT to the adventitia side of femoral 
artery after de-endothelialization injury accelerates neointimal hyperplasia.4 However, most studies 
have attributed the function of PVAT to cytokines such as monocyte chemoattractant protein 1 
(MCP1), and little is known about the possible impact of stem cells in the PVAT surrounding the 
vascular wall.3, 4  
      Tissue-resident stem cells, including vascular progenitors, are responsible for tissue remodeling.5, 6 
Adventitial stem/progenitor cells participate in vascular remodeling through migration towards the 
injury site and differentiation towards vascular lineages including SMCs.7 Adipose tissue-derived 
mesenchymal stem/stromal cells (ADSCs) from the subcutaneous and visceral fat display the potential 
to differentiate towards vascular lineages including endothelial cells (ECs) and smooth muscle cells 
(SMCs).8, 9 Therefore, it remains to be explored whether perivascular adipose tissue-derived 
mesenchymal stem cells (PV-ADSCs) exist in the PVAT and contribute to vascular remodeling 
through vascular lineage differentiation in vivo like adventitial stem/progenitor cells.  
      Mesenchymal stem cells (MSCs) from different tissues origins display similar phenotypic 
characteristics and multi-lineage differentiation potential in vitro, however, their well-documented 
heterogeneity has hindered major research progress in the field. Single-cell RNA-sequencing 
(scRNA-seq) analysis allows transcriptome profiling at the single-cell level and might help to gain 
further insight about distinctive sub-populations.10 Recent studies have shown that metabolism which 
primarily sustains the energy need of stem cells regulates pluripotency and differentiation.11 For 
example, fatty acid oxidation was found to be important for hematopoietic stem cell maintenance.12 
To date, whether the induction of SMC differentiation by TGFb1 is in part due to the metabolic 
regulation has not been investigated.  
      In this study, we demonstrate the heterogeneity of PV-ADSCs at a single-cell level and uncover 
two distinct clusters with specific signature markers and signaling pathways. Next, we show that PV-
ADSCs participate in vascular remodeling in vivo notably through SMC differentiation. In addition, 
we demonstrate that during the SMC differentiation of PV-ADSCs, TGFb1 and miR-378a-3p induce a 
metabolic reprogramming consisting of increased mitochondrial oxidative metabolism, upregulated 
mitochondrial potential and altered lipid levels such as increased cholesterol level. Therefore, our 
study highlights the heterogeneity of PV-ADSCs at the single-cell level, unravels their importance in 
vascular remodeling and presents miR-378a-3p as a potential therapeutic target to prevent 
pathological vascular remodeling. 
 
Materials and Methods 
The data that support the findings of this study are available from the corresponding author upon 
reasonable request. Detailed materials and methods are in the online-only Data Supplement. 
Experimental Mice  
All animal procedures were approved by the UK Home Office. C57BL/6J mice were purchased from 
The Jackson Laboratory. Male mice aged 8-10 weeks were selected for surgery. Only male mice were 
selected for minimization of data variation brought by difference of sex. Breeding pairs of miR-378a-
knockout mice (129SvEv/C57BL/6/mir-378-KO) were kindly provided by Dr. Eric Olson (University 
Texas Southwestern Medical Centre, Dallas, USA) and crossed with C57Bl/10ScSn-Dmdmdx/J mice 
for testing miR-378a effects in Duchenne muscular dystrophy (other work, in preparation). Protocols 
from the Institutional Committee for Use and Care of Laboratory Animal and license issued by Home 
Office UK were followed in all animal procedures.  
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Primary Culture of Adipose Tissue-derived Stem Cells from Mouse 
Peri-aorta adipose tissues surrounding thoracic aorta (from the aortic arch to the aortic hiatus) of five 
8-week-old C57BL/6J mice were pooled for each primary culture. Finely minced adipose tissue was 
washed with PBS once and then digested with 2 mg/ml Collagenase type I (Life Tech, 17018-029) for 
30 min at 37°C in a shaker with a speed set at 100 rpm. The pellet was resuspended in stem cell 
culture medium [αMEM with 15% Embryomax (Millipore, ES-009-B), 0.1mmol/L 2-mercaptoethanol 
(Sigma), 10 ng/ml recombinant human leukemia inhibitory factor (Chemicon, Temecula, CA), 5ng/ml 
bFGF (R&D systems), 2 mmol/L L-glutamine (Sigma), 100 U/ml penicillin, and 100 mg/ml 
streptomycin (GIBCO, Grand Island, NY)] and placed in a 5% CO2 incubator. ADSCs from miR-
378a knockout mice were isolated from the inguinal subcutaneous adipose tissue and cultured in the 
same manner. Cells within 10 passages were used. 
Phenotyping of Primary and Cultured PV-ADSC 
Primary cells obtained after the enzymatic digestion of peri-aorta adipose tissue or cultured cells 
detached with scraptase (GenDEPOT) were stained for 30 minutes at 4 °C with following antibodies: 
anti-CD45-APC (BD Biosciences, 561018), anti-CD29-PE (BD Biosciences, 562801), anti-Sca-1-PE-
Cy7 (Biolegend, 108113), anti-CD31-PerCP (Biolegend, 201419), anti-CDH5-Alexa Fluor 647 (BD 
Biosciences, 562242), anti-PDGFRa-APC (eBioscience, 17-1401-81), anti-CD117-PE (Biolegend, 
105807), anti-CD34-APC (Biolegend, 128611), anti-CD44-PerCP (Biolegend, 103035) and anti-
CD11b-PE (Biolegend, 101205). Nucleated cells were distinguished from debris with Syto16 
(Molecular Probes, S7578) and dead cells with DAPI. Cells were analyzed with BD Accuri C6 or BD 
LSR Fortessa II (both Becton Dickinson). Gating was set with appropriate fluorescence minus one 
controls or corresponding IgG controls.  
Sorting and scRNA-seq of PV-ADSCs 
Peri-aorta adipose tissue surrounding thoracic aorta (from the aortic arch to the aortic hiatus) was 
enzymatically digested to obtain primary PV-ADSCs. The cell suspensions were stained with Syto16, 
DAPI, CD45, CDH5, CD29, and Sca1 as described earlier in the phenotyping of primary and cultured 
PV-ADSCs. After proper gating, the single Syto16+/DAPI-/CD45-/CDH5-/CD29+/Sca1+ population 
were taken for subsequent scRNA-seq. RNA libraries were prepared on the contactless liquid 
handling system Labcyte Echo 525 (Labcyte Inc). Data quality was assessed with FastQC, reads were 
aligned to mouse genome (mm9) with HiSat2 2.0.5, sorted with SamTools 1.4 and assembled with 
StringTie 1.3.3.13 R package scater was used for quality control (85 out of 94 cells with aligned reads 
greater than 800,000 were selected for further analysis) and normalization (default scaling 
normalization).14 Automated Single-cell Analysis Pipeline (ASAP) with log-transformed and 
normalized values as input was used for multi-dimensional scaling (MDS), clustering, differential 
expression (DE method: SCDE).15 Heatmaps and violoin plots of scRNA-seq data were plotted with R 
package ggplot2. Gene ontology (GO) and KEGG pathway analysis were performed with DAVID 
website.16 Gene set enrichment analysis was carried out with GSEA software.17 
For scRNA-seq of cultured PV-ADSCs, enzymatically digested cells that attached to the flask surface 
after 3 days (in αMEM with 10% FBS) and reached 80% confluency were dissociated and 
encapsulated in a gel bead and loaded to GemCode Instrument (10X Genomics) which generated 
barcoded single-cell droplets. Sequencing was carried out with standard protocol using 10X Single 
Cell 3’ v2 and 10X chromium system. The library was sequenced with Nova PE150. In total, 12,158 
cells were sequenced in one run. R package Seurat (version 2.3.0)18 was leveraged for subsequent 
quality control and clustering analysis. Cells expressing <200 or >5000 genes were filtered out for 
exclusion of noncell or cell aggregates. Cells with a percentage of mitochondrial genes >0.05 were 
also filtered out. After quality control, 11,878 cells were included in subsequent analysis. After log-
normalizing the data, principle component analysis was performed for dimension reduction. Clusters 
generated with the first 10 principal components were visualized with t-distributed stochastic nearest 
neighbor embedding. Expression of selected genes was plotted with Seurat function FeaturePlot.  
Adult subcutaneous adipose tissue stromal vascular cells in published datasets (GSM371797819 and E-
MTAB-667720) were analyzed with corresponding methods described in the literature. Clustering-
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specific markers for each mesenchymal stem cell population were found with MSC population 
subseted Seurat (version 3) object. 
Pseudotime Trajectory Analysis 
Pseudotime trajectory was plotted with R package monocle version 2.4 with default settings. 
Pseudotime ordering was performed using function reduceDimension with max_components set at 2 
and reduction_method set as DDRTree. Cells that express Acta2 but don’t express Myl6, Cnn1 or 
Myh11 were set as starting point of pseudotime. Significant genes are obtained with function 
differentialGeneTest (fullModelFormulaStr = “~Pseudotime”) and plotted with function 
plot_pseudotime_heatmap (num_clusters = 3). In the heatmap, predicted values generated by function 
genSmoothCurves were plotted along 100 evenly spaced pseudotime values.21 Genes included in 
KEGG term TGFb signaling or transcription factors (list obtained from transcription factor database22) 
were intersected with the 3 significantly changed gene modules and presented as heatmap. Branch 
point analysis was performed with BEAM function. 
Smooth Muscle Differentiation 
PV-ADSCs were seeded on gelatin-coated flasks and differentiated with medium [αMEM with 10% 
FBS and 5 ng/ml TGFb1 (R&D systems)] for indicated time. Leptin (Peprotech, 450-31) or IGFBP2 
(R&D Systems, 797-B2-025) at indicated concentrations were used to manipulate differentiation. 
RFP Labeling of Cells  
Lentiviral particles used to label PV-ADSCs with RFP were generated with LV H2b_RFP plasmid23 
(a gift from Elaine Fuchs, Addgene, 26001).  
Subcutaneous Matrigel plug assay 
Subcutaneous Matrigel plug assay experiments were conducted as described.6, 24, 25 PV-ADSCs were 
differentiated for 5 days with αMEM with 10% FBS 5 ng/ml TGFb1. Mouse MS1 ECs (ATCC, CRL-
2279) were prepared. Differentiated PV-ADSCs and mouse ECs were mixed in a 1:1 ratio in 100 μl 
Matrigel and injected subcutaneously to mice. The pl gs were harvested 14 days after the injection 
for immunostaining and H&E staining. To track the PV-ADSCs, RFP-labeled cells were used. 
Cell Transplantation 
Mouse vein segments were iso-grafted into carotid arteries of C57BL/6J mice.26 RFP-labeled PV-
ADSCs in culture (106 cells) were seeded onto the adventitial side to envelope the vein grafts. Vein 
graft transplantation without cell wrapping was used as control. Grafted tissue fragments were 
harvested 2 weeks post-surgery and stained with H&E and immunofluorescent markers. 
1H NMR (nuclear magnetic resonance) metabolomics analysis 
Undifferentiated ADSCs and ADSCs cultured in differentiation medium (αMEM with 10% FBS and 
5 ng/ml TGFb1) for 1 day were harvested and frozen in liquid nitrogen. Eight samples were acquired 
in each treatment and 1H NMR metabolomics was carried out using method published with 
modifications.27    
GC-MS (Gas Chromatography – Mass Spectrometry) metabolomics analysis 
Undifferentiated ADSCs, ADSCs differentiated for 4 days, cells treated with miRNA mimic negative 
control or miR-378a-3p mimics were harvested, frozen in liquid nitrogen before analysis. Extraction 
of metabolites were done using a published protocol with modification.28 
Metabolomics Data Processing 
Annotated metabolites and correspondent abundance were normalized to the total level of metabolites. 
Data scaling was mean-centered and divided by standard deviation of each variable. Orthogonal 
projection to latent structures analysis29 and heatmap of various metabolites were obtained from 
MetaboAnalyst software.30  
Transfection of miRNA mimics, miRNA inhibitors and siRNAs 
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PV-ADSCs with 70% confluence were transfected with miRNA mimics, inhibitors or siRNAs 
(Thermo Fisher) with Lipofectamine RNAiMAX (Thermo Fisher). After optimization, the 
concentrations of miRNA mimics, miRNA inhibitors and siRNAs were respectively 12.5, 60 and 12.5 
nmol/L.  
Oxygen consumption rate and extracellular acidification rate measurements 
Oxygen consumption rate and extracellular acidification rate are measured with the Seahorse XF-24 
extracellular flux analyzer (Seahorse Bioscience). PV-ADSCs with indicated treatments and 
corresponding controls were plated on XF24 microplate coated with gelatin one day prior to the assay. 
XF Cell Mito Stress Kit was used to study the mitochondrial metabolism. OCR and ECAR at basal 
level and after metabolic perturbations with the addition of 1 μmol/L oligomycin, 1 μmol/L carbonyl 
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) and 1 μmol/L rotenone and antimycin A were 
measured. Calculations were obtained with the Agilent Seahorse Wave Software for Agilent Seahorse 
XF analyzers (Seahorse Bioscience).  
Statistical Analysis  
Data with 5 or more experiment repeats passed KS normality test that determines data normality 
and the F-test that assesses homogeneity of variance. Unpaired and two-tailed student’s t test 
were applied to analyze data between two groups. Data were expressed as mean±SD (standard 
deviation) using GraphPad Prism 6. Comparisons across multiple groups with 5 experiment 
repeats per group were assessed with one-way ANOVA test, followed by Bonferroni post-hoc 
analysis. Comparisons across multiple groups with 3 experiment repeats per group were assessed 
with Kruskal-Wallis test, followed by Bonferroni post-hoc analysis. Experiment repeats in each 
group were specified in the figure legends. P value < 0.05 was considered statistically different. 
Data Availability 
Clustering result of primary PV-ADSC scRNAseq data has been made public on the ASAP website 
(https://asap.epfl.ch) with the project name PV-ADSC scRNAseq. Raw sequencing data of primary 
PV-ADSCs are available in Gene Expression Omnibus (GSE132581). Additional data are available 
from the corresponding author upon request. 
 
Results 
Characterization and Localization of Stem Cells in the Perivascular Adipose Tissue 
MSCs exist in almost all organs of the body.31 Adipose tissue-derived MSCs from the subcutaneous 
fat exhibit potential for tissue remodeling with multi-lineage differentiation capacities and 
immunomodulation effect.32 Thus, we hypothesized that MSCs also reside in the PVAT. To examine 
this, the adipose tissue surrounding mouse thoracic aorta was enzymatically digested and cultured in 
vitro. In the isolated adipose tissue, similar coverage of PLIN1 (Perilipin1), an adipocyte marker with 
cell nucleus as well as minimal staining of PLIN1 in remaining adventitia confirms minimal 
contamination of adventitial cells (Figure I in the online-only Data Supplement), although slight 
contamination could not be excluded given the proximity of peri-aorta adipose tissue and adventitia. 
More than 95% of the cells express MSC marker CD29 and 73.55% ± 2.85% express mouse stem cell 
marker Sca1 (Figure 1A and 1B). CD34, which is also an MSC marker33, displayed high expression in 
around 68.30% ± 2.70% of the cultured cells (Figure 1A and 1B). Furthermore, only 1~3% of the 
cells express hematopoietic marker CD45, macrophage marker CD11b, progenitor marker c-Kit, and 
endothelial marker PECAM1 (Figure 1A and 1B). In addition, around 63% of the cells expressed 
pericyte or fibroblast marker PDGFRa and more than 95% expressed CD44 (Figure IIA in the online-
only Data Supplement). Furthermore, the cells isolated from the PVAT exhibited adipogenic and 
osteogenic differentiation capacities (Figure IIB-IIE in the online-only Data Supplement). Thus, in 
consistency with the in vitro definition of MSCs proposed by the International Society for Cellular 
Therapy34, phenotypic analysis and multi-lineage differentiation capacities confirmed the existence of 
MSCs within the peri-aorta adipose tissue. These cells are referred to as PVAT-derived mesenchymal 
stem cells (PV-ADSCs) below.  
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      After characterization of the phenotypic markers, the in situ localization of PV-ADSCs was 
studied. To exclude endothelial cells and adipocytes from the PV-ADSC population, staining of 
endothelial marker PECAM1 and adipocytes marker PLIN1 was performed. MSC marker CD29 was 
utilized because of its consistent and high expression in primary peri-aorta adipose tissue cells (Figure 
2A) and cultured PV-ADSCs (Figure 1). As adventitial Sca-1+ cells play a crucial role in neointima 
formation and vascular pathogenesis35, Sca-1 expression in CD29+/PECAM1-/PLIN1- cells was 
examined. The results showed that PVAT contains a population of CD29+/PLIN1-/PECAM1- cells and 
that some of the cells co-express Sca-1 (Figure 1C). To conclude, a CD29+/Sca1+/PLIN1-/PECAM1- 
PV-ADSC population was identified in the PVAT. 
ScRNA-seq of PV-ADSCs Reveals Two Distinct Clusters 
Heterogeneity has been a long-standing question in the research field of MSCs.34 To achieve a high-
resolution phenotyping of the PV-ADSCs, scRNA-seq was utilized. Among the enzymatically 
digested peri-aorta adipose tissue cells (freshly isolated cells without in vitro culture), single live cells 
were sorted for CD45-/CDH5- population to exclude the hematopoietic and endothelial lineages 
(Figure 2A). Subsequently, scRNA-seq was performed in CD29+/Sca1+ cells (60.15% ± 3.17% in 
non-immune non-endothelial cells) (Figure 2A and Figure IIIA in the online-only Data Supplement). 
Selection of CD29 and Sca1 as the positive markers of PV-ADSCs was supported by our previous 
phenotypic and in situ characterization and previous publications.20, 36 Interestingly, Dpp4+ interstitial 
progenitors in mouse subcutaneous inguinal white adipose tissue showed an enrichment of Sca1 
compared to committed Icam1+ proadipocytes (Figure IIIB in the online-only Data Supplement), 
which further supported the use of Sca1 for enrichment of ADSCs.19   
     Among the 94 single cells captured, 85 cells with the number of aligned reads greater than 800,000 
were selected for further analysis (Figure IIIC in the online-only Data Supplement). Two distinct 
clusters (cluster 1 and cluster 2) were identified which contained 30 and 55 cells respectively (Figure 
2B). Cluster 2 featured the expression of Tgfbr2, an important component of TGF-beta signaling 
pathway (Figure 2C), whereas cluster 1 exclusively expressed Pecam1 (Figure IIIH in the online-only 
Data Supplement), an endothelial marker and Cd36 (Figure 2C and 2D), which is important for fatty 
acid uptake. The signature genes for cluster 1 and 2 were illustrated as a heatmap (Figure 2D). 
Important signaling pathways in cluster 1 included VEGF-activated receptor activity and PPAR 
signaling (Figure 2E). The feature signaling pathways for cluster 2 were those essential in smooth 
muscle differentiation such as PDGF binding, IGF binding, PI3K-Akt signaling and TGF-beta 
signaling (Figure 2F). Furthermore, gene sets of myogenesis and TGF-beta signaling presented a 
positive correlation with cluster 2 (Figure 2G). The results implied that cluster 1 cells display 
angiogenic potential, whereas cluster 2 cells demonstrate enriched expression of genes involving 
pathways that are important in SMC differentiation. 
     Single-cell level examination of MSC or pericyte markers including Mcam31, Tbx1837, Cspg431 and 
Pdgfra36 etc. revealed substantial heterogeneity at a high resolution (Figure 2H). High expression of 
Ly6a was observed in both clusters, while other markers such as Cd34, Cd44, Pdgfra and Pdgfrb were 
mainly expressed in cluster 2 (Figure 2I). Heterogeneous expression of stemness markers such as Klf4 
and Myc38 was also observed (Figure IIID in the online-only Data Supplement). Additionally, the cells 
in cluster 1 demonstrated exclusive expression of adipogenesis markers Fabp4 and Pparg (Figure IIIE 
and IIIF in the online-only Data Supplement). Endothelial marker Cdh5 was also mainly expressed in 
cluster 1 cells (Figure IIIG and IIIH in the online-only Data Supplement). No cell expressed SMC 
markers including Cnn1, Tagln, Acta2 and Myh11 (not shown). Interestingly, fibroblast markers such 
as Vimentin demonstrated heterogeneous expression in primary PV-ADSCs (Figure IV in the online-
only Data Supplement). Relatively limited heterogeneity resulted from the relatively small number of 
cells analyzed was complimented by analysis of published datasets which offered clue of 
subcutaneous stromal vascular cell hierarchy (Figure V in the online-only Data Supplement).19, 20 To 
conclude, scRNA-seq allowed unprecedented direct visualization of MSC heterogeneity, revealing 
two distinct clusters with discrete signature gene sets and signaling pathways. Multiple gene sets 
involved in SMC differentiation were enriched in cluster 2.  
Pseudotime Analysis of Cultured PV-ADSCs Uncovers a SMC Differentiation Trajectory 
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While scRNA-seq of primary PV-ADSCs reflected their function and heterogeneity in vivo, further 
scRNA-seq of cultured PV-ADSCs offered an opportunity to examine a larger number of cells. In 
total, 12,158 cells were detected, with a median 2,602 genes per cell. After quality control by 
including cells with gene number between 200 and 5,000 and filtering out cells with fraction of 
mitochondrial genes higher than 0.05, 11,878 cells were leveraged for subsequent analysis (Figure 
VIA and VIB in the online-only Data Supplement). Consistent with our previous flow cytometry data 
(Figure 1A), cultured PV-ADSCs exhibited minimal level of Cdh5 expression with only 0.48% of the 
cells positive for Cdh5 (Figure VIC and VIE in the online-only Data Supplement). On the contrary, 
Tgfbr2 and Col3a1, both marker genes of cluster 2 in primary PV-ADSCs, displayed high expression 
in cultured PV-ADSCs with 29.26% and 93.79% of the cells positive for these markers respectively 
(Figure VIC and VIE in the online-only Data Supplement). Interestingly, 6.23% of the cells expressed 
mature SMC marker Myh11 (Figure VID and VIE in the online-only Data Supplement). Additionally, 
most of the 15 cluster 1 marker genes displayed expression in less than 5% cultured cells, whereas 
most of the cluster 2 marker genes were expressed in more than 25% of the cultured cells (Figure VIF 
in the online-only Data Supplement).  
     Pseudotime trajectory analysis was employed to inspect progression of continuous cell states. It is 
noted here that the trajectory here was not complimented by real differentiation time points and thus 
offers only suggestions of differentiation mechanism, which requires further experimental proof. 
Since the PV-ADSCs were kept in basal conditions without additional stimulation factor towards 
adipocytes or osteocytes, minimal expression of markers for these cell types were expressed (Figure 
VIIA in the online-only Data Supplement). Cultured PV-ADSCs displayed different level of Acta2, 
Myl6, Cnn1 and Myh11 expression (Figure 3A and Figure VIIB in the online-only Data Supplement). 
Pseudotime analysis ordered cells expressing different levels of SMC markers in a trajectory (Figure 
3B). Mature SMCs (stage 4) was located towards the termini of the trajectory, which is partly a 
validation for the constructed trajectory (Figure 3C). Significantly changed genes along the 
pseudotime trajectory were assigned to three gene modules (Figure 3D). In the downregulated gene 
module were Lpl (Figure 3D), an enzyme important for lipid metabolism39, stem cell marker Ly6a 
(Figure 3E) and fibroblast marker Dcn (Figure VIIB in the online-only Data Supplement). Vim and 
Tpm3 were from gene module 2 and upregulated along the pseudotime, peaking in the middle of the 
trajectory (Figure 3D). SMC marker Acta2, pericyte marker Mcam, and MSC marker Cd44 were in 
gene module 3, reaching highest expression towards the end of trajectory (Figure 3D). For the 
upregulated genes (gene module 2 and 3), essential pathways for SMC differentiation such as HDAC 
binding, histone binding, acting binding, IGF binding and TGFR binding were enriched (Figure 3F). 
In the TGF-b signaling pathway, the upregulation of Tgfb1 (in gene module 2), Rock2 and Rhoa (in 
gene module 3) along pseudotime trajectory further underlines the importance of this pathway in 
SMC differentiation (Figure 3G). In particular, Tgfb2 and also the total level of significantly changed 
genes in TGF-b signaling were increased during differentiation (Figure 3H). Importantly, along the 
trajectory, Cebpb, which is crucial for adipogenesis, and Runx1, which drives osteocyte 
differentiation40, decreased (Figure 3I). It is noted that pseudotime heatmap plots predicted values 
generated by function genSmoothCurve in monocle (version 2) along 100 evenly spaced pseudotime 
values rather than real expression values.21 Cells located at the branches of the trajectory including 
states 8, 7, 5 and 9 demonstrated enriched expression of genes involved in GO terms antioxidant 
activity, laminin binding, hormone receptor binding and IL1 activity receptor binding respectively, 
which is consistent with the broad spectrum of function reported for mesenchymal stem cells such as 
immunomodulation (Figure VIII in the online-only Data Supplement).41 
PV-ADSCs Participate in Vascular Remodeling in vivo and Differentiate towards SMCs in vitro 
Both adventitial progenitors and PV-ADSCs are located close to the aorta, among which adventitial 
progenitors have been demonstrated to participate in vascular remodeling.7 To better characterize PV-
ADSCs, comparison of their single-cell level transcriptomic signature with adventitial mesenchyme 
cells (Adventitial Mesen I-IV clusters)42 were performed. Cluster-defining genes for Adv-Mesen cells 
were enriched in cluster 2 cells of primary PV-ADSCs, with Mesen II cluster markers most highly 
expressed (Figure IXA in the online-only Data Supplement). Additionally, only cluster 2 markers 
were highly expressed in Adv-Mesen cells and their slight enrichment in Mesen II cluster was also 
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observed (Figure IXB in the online-only Data Supplement). Comparison of Sca1+ (normalized 
expression > 1) cells from Adv-Mesen cells and cultured PV-ADSCs was further conducted. 
Interestingly, Ccl2 (C-C motif chemokine ligand 2), which proved important for the pro-inflammatory 
function of adventitial Sca1+ cells42, was among the genes with high variation in both groups (Figure 
IXC from online-only Data Supplement). Various genes were differentially expressed in Sca1+ Adv-
Mesen cells and cultured PV-ADSCs, among which fibroblast marker Dcn (decorin) and actin 
filament regulating Gsn (gresolin) were enriched in Adv-Mesen cells, and Timp1 (tissue inhibitor of 
metalloproteinases 1) and S100a4 (S100 calcium binding protein A4) were highly expressed in 
cultured PV-ADSCs (Figure IXD and IXE in the online-only Data Supplement). In terms of pathway 
analysis, genes expressed higher in cultured PV-ADSCs displayed enrichment of GO terms actin 
binding and actin filament binding, whereas those selectively expressed in Adv-Mesen cells were 
enriched for GO term chemokine activity and antioxidant activity (Figure IXF in the online-only Data 
Supplement). However, it should be noted that cultured PV-ADSCs and primary Adv-Mesen cells 
were compared. Cell culture conditions might introduce transcriptomic difference. Collectively, 
cluster 2 PV-ADSCs displayed certain similarity with adventitial Sca1+ cells, whereas transcriptomic 
difference was more prominent.   
     To explore whether PV-ADSCs participate in vascular remodeling in vivo, a vein graft model was 
used. Transplantation of cultured PV-ADSCs to the adventitia side of the vein graft significantly 
promoted the neointima formation (Figure 4A). RFP signal in the neointima area indicated the 
migration of the RFP-labeled PV-ADSCs from the adventitia side to the intima (Figure 4B). 
Numerous RFP positive cells expressed SMC marker ACTA2, implying that the contribution of PV-
ADSCs to neointima formation might be partly through SMC differentiation (Figure 4B). Fibroblast 
marker Vimentin was also expressed in some RFP-positive cells (Figure XA in the online-only Data 
Supplement). Notably, no co-localization of RFP with macrophage marker CD68 was observed, 
suggesting that participation of PV-ADSCs in vascular remodeling was not through macrophage 
differentiation (Figure XB in the online-only Data Supplement).  
     After establishing that PV-ADSCs contribute to vascular remodeling partly through SMC 
differentiation in vivo, their potential to differentiate towards SMCs in vitro was next explored for 
subsequent mechanism study. TGFb1 was utilized as stimulus for differentiation, given the role of 
TGFb1 signaling in SMC differentiation implied by scRNA-seq. Upon treatment with TGFb1, PV-
ADSCs differentiated towards SMCs, as displayed by the upregulation of SMC markers including 
Cnn1, Tagln and Acta2 at the mRNA and the protein level (Figure 4C-4E). Collagen gel contraction 
assay demonstrated better contractility of SMCs differentiated from PV-ADSCs (Figure XI in the 
online-only Data Supplement). Since brown adipose tissue has been gradually recognized as a 
secretory organ, we also checked the effect of IGFBP-2, an adipokine secreted predominantly by 
brown adipose tissue43, on PV-ADSC differentiation towards SMCs. High concentration (250 ng/ml) 
IGFBP-2 promoted SMC differentiation with the presence of TGFb1, whereas no effect was observed 
for leptin, an adipokine secreted mainly by white adipose tissue (Figure XIIA and XIIB in the online-
only Data Supplement). Interestingly, PV-ADSCs also expressed high level of IGFBP-2 in 
comparison with ADSCs isolated from subcutaneous adipose tissue (Figure XIIC in the online-only 
Data Supplement). Additionally, PV-ADSC migration towards chemoattractant SDF1 was also 
observed (Figure 4F), consistent with the notion that participation of PV-ADSCs in vivo involves 
complex processes including differentiation and migration.7 
     To further investigate the function of SMCs differentiated from PV-ADSCs, the cells were mixed 
with mouse MILE SVEN 1 ECs in Matrigel and then injected subcutaneously in wild-type mouse to 
check their ability to participate in vasculogenesis with the assistance of mature ECs. As exhibited by 
H&E staining of the subcutaneous Matrigel plug, a relatively large tube-like structure with multiple 
layers was formed in the plug with differentiated PV-ADSCs and ECs, whereas it was not found in 
control group (Figure 4G). Immunostaining of the Matrigel plug showed proximal localization of 
ACTA2 and PECAM1, demonstrating that the tube-like structure was a vessel (Figure 4H). 
Altogether, functional SMCs can be derived from PV-ADSCs.  
Metabolic Reprogramming of PV-ADSCs during SMC Differentiation Induced by TGFb1  
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Metabolic reprogramming in stem cells not only helps to meet the energy requirement, but also drives 
various processes such as differentiation.44 To investigate metabolic changes in the SMC 
differentiation of PV-ADSCs induced by TGFb1, NMR (nuclear magnetic resonance) metabolomics 
was firstly performed. Abundance of various detected metabolites demonstrated notable changes 
during differentiation (Figure 5A). Orthogonal projection to latent structures analysis depicted the 
distinct metabolic status of differentiated PV-ADSCs (Figure 5B). Functionally, cells treated with 
TGFb1 exhibited higher basal mitochondrial oxygen consumption rate (OCR), higher maximal 
mitochondrial OCR as well as stronger spare respiration capacity (SRC) (Figure 5C). Consistently, 
higher mitochondrial potential was detected in differentiated PV-ADSCs (Figure 5D). These results 
implied that the mitochondrial oxidative metabolism was enhanced during differentiation.  
      Further characterization of the metabolic change was examined with GC-MS metabolomics which 
is more sensitive and detects more metabolites. Enrichment of metabolites from tricarboxylic acid 
(TCA) cycle (Figure 5E) during differentiation indicated the increased mitochondrial activity, which 
was consistent with the upregulated OCR and mitochondrial potential. Fueled by the observation that 
mitochondrial activity was increased during differentiation, we postulated that the reactive oxygen 
species (ROS) might influence SMC differentiation. However, SMC markers were not altered by the 
treatment of H2O2 (Figure XIIIA in the online-only Data Supplement) or the transfection of Nox4 
siRNA (Figure XIIIB in the online-only Data Supplement) which changed the ROS level. Treatment 
of FCCP which potently uncoupled the electron transduction and oxidative phosphorylation also 
displayed only mild effect on SMC marker expression (Figure XIIIC in the online-only Data 
Supplement). Notably, as indicated by the increased phosphoenolpyruvate and lactate level (Figure 
XIIID in the online-only Data Supplement), glycolysis was also upregulated during differentiation. 
Functional characterization of glycolysis showed the upregulation of both the basal glycolysis and 
glycolysis capacity in cells treated with TGFb1 (Figure XIIIE in the online-only Data Supplement). 
However, glucose uptake did not show much change and glucose treatment did not have effect on the 
SMC marker expression (Figure XIIIF and XIIIG in the online-only Data Supplement).  
      More extensive examination of the GC-MS metabolomics data revealed the upregulation of 
various lipids in differentiated PV-ADSCs (Figure 5F). The increased lipid together with the more 
active mitochondria suggested a potential change of lipid metabolism. Significant changes in Ppara, 
Pparg, Prdm16, Ucp1, Cebpb and Cebpd were observed during SMC differentiation, supporting the 
hypothesis that lipid metabolism drastically reprogrammed during differentiation (Figure 5G). 
Changes of these markers along the trajectory and in real time further supported the reprogramming of 
lipid metabolism (Figure 5H and Figure XIV in the online-only Data Supplement). The change of 
various lipid levels led us to investigate the lipid oxidation process, which relies on the trans-
mitochondrial transport of fatty acids regulated by carnitine acyltransferases including carnitine 
palmitoyltransferase 1 (Cpt1) and carnitine acetyltransferase (Crat).45 Cpt1 is responsible for the 
transport of long-chain fatty acids and Crat is responsible for the transport of short-chain fatty acids.45 
Cpt1a and Cpt1b were not altered with the treatment of TGFb1 for 2 days(Figure 5G), although Cpt1a 
displayed downregulation along trajectory (Figure XIV in the online-only Data Supplement). 
Moreover, Crat level was significantly downregulated first and then upregulated during SMC 
differentiation, which is supported by the early downregulation and late upregulation of Crat level 
along SMC trajectory (Figure 5I and Figure XIV in the online-only Data Supplement). Thus, 
significant metabolic reprogramming was induced during SMC differentiation, and altered lipid 
metabolism implied the involvement of Crat in SMC differentiation. 
TGFb1 Promotes SMC Differentiation via Inhibition of Crat 
In SMC differentiation, TGFb1 altered the lipid profile and inhibited the level of Crat. To confirm the 
role of Crat in SMC differentiation, siRNA Crat was utilized. Q-PCR showed successful knockdown 
of Crat 2 days after Crat siRNA transfection (Figure 6A). SMC markers including Cnn1, Tagln and 
Acta2 were induced at the mRNA level (Figure 6A) by Crat siRNA transfection. Promotion of SMC 
differentiation by Crat knockdown was demonstrated at the protein level by Western blot (Figure 6B) 
and immunofluorescent staining (Figure 6C) 2 days after Crat siRNA transfection. The upregulation 
of TGFb1 at the mRNA level (Figure 6D) and the protein level (Figure 6E and 6F) 2 days after Crat 
siRNA transfection identified the induction of TGFb1 as the downstream mechanism of Crat-
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mediated SMC differentiation. To conclude, an interesting feedback control was identified between 
Crat inhibition and TGFb1 induction during differentiation. 
MiR-378a-3p Induces Metabolic Reprogramming and Promotes SMC Differentiation 
After establishing the change of the metabolic profile during differentiation process and the 
mechanism involved in SMC differentiation, potential therapeutic targets that could similarly alter the 
metabolic profile and drive SMC differentiation were investigated. Literature mining revealed that 
miR-378a-3p could target Crat and thus regulate fatty acid metabolism which was regulated by 
TGFb1 in our SMC differentiation system.46 To study the role of miR-378a-3p in metabolic 
reprogramming and SMC differentiation, PV-ADSCs were transfected with miR-378a-3p mimics. In 
Seahorse Mito Stress tests, both the basal OCR and maximal OCR showed an increasing trend with 
miR-378a-3p mimic treatment compared with control (Figure 7A). Furthermore, the mitochondrial 
potential also increased (Figure 7B). Metabolite abundance detected by GC-MS system demonstrated 
the enrichment of metabolites involved in the TCA cycle (Figure 7C) and upregulated level of various 
lipids such as cholesterol (Figure 7D). Overall, the metabolic reprogramming induced by the miR-
378a-3p mimics was similar to that induced by TGFb1. Furthermore, miR-378a-3p mimics induced 
SMC differentiation with the significant upregulation of Cnn1 and Tagln (Figure 7E). The induction 
of SMC gene expression was confirmed at the protein level (Figure 7F and Figure XVA in the online-
only Data Supplement). On the contrary, miR-378a-3p inhibitor downregulated mRNA level of SMC 
markers (Figure 7G). In addition, Crat expression was also de-repressed in PV-ADSCs after the 
transfection of miR-378a-3p inhibitors (Figure 7G).  
      Finally, TGFb1 treatment could not induce an upregulation of OCR and ECAR in ADSCs derived 
from miR-378a-3p knock out mice (Figure 7H), further confirming the importance of miR-378a in 
inducing metabolic reprogramming. Also, SMC differentia ion capacity was significantly attenuated 
in ADSCs derived from miR-378a knockout mice as shown by the lower level of CNN1 compared 
with ADSCs from wild type mice after the treatment with TGFb1 (Figure 7I and Figure XVB in the 
online-only Data Supplement). Interestingly, level of miR-378a-3p was downregulated by TGFb1 
treatment (Figure XVC in the online-only Data Supplement). In summary, metabolic reprogramming 
and SMC differentiation were induced by miR-378a-3p, which was an indispensable component for 
TGFb1 to exert the metabolic regulation.  
 
Discussion 
In this study, we characterized the transcriptomic profile of PV-ADSCs at a single-cell level and 
determined their role in vascular remodeling through their differentiation towards smooth muscle 
lineage which was accompanied by metabolic reprogramming. Substantial heterogeneity was 
observed at the single-cell level in primary PV-ADSCs. Moreover, through differentiation towards 
smooth muscle lineage, cultured PV-ADSCs were suggested to contribute to vascular remodeling in 
vein graft models. Mechanistically, SMC differentiation from PV-ADSCs was accompanied by a 
metabolic reprogramming which could be induced by miR-378a-3p.  
      To characterize the PV-ADSCs, scRNA-seq was performed and revealed two distinct clusters 
within the CD45-/CDH5-/CD29+/Sca1+ population, as well as the signature gene sets and feature 
signaling pathways for each cluster. However, attention needs to be paid to the markers used to 
identify the MSCs. About 60.15% ? 3.77% of the CD45-/CDH5- population were CD29+/Sca1+. Thus, 
the scRNA-seq result only covers this population and remaining cells necessitate further 
characterization. Furthermore, multiple cluster 1 markers including Pecam1 and Cd36 displayed low 
percentage expression in in vitro cultured PV-ADSCs, which suggested difficult retainment of these 
markers in present culture condition or selective expansion of cluster 2 cells. Future efforts including 
selective culture of cells from each cluster and separate determination of their contribution to vascular 
remodeling are needed.   
      Consistent with what has been reported for MSCs47, 48, considerable heterogeneity of PV-ADSCs 
has been observed in our study, which serves as direct evidence for stem cells from the perivascular 
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(peri-aorta) adipose tissue. Although transcriptional network heterogeneity of  stromal vascular 
fraction from axillary adipose tissue was reported49, perivascular adipose tissue is more relevant to 
vascular function.1 With scRNA-seq, heterogeneous intracellular markers and functional modules 
have also been described in our study. Due to this substantial heterogeneity, markers that are used to 
identify MSC population by itself, such as Tbx1837, might only label a sub-population. To overcome 
the laborious efforts to generate lineage tracing models for all the heterogeneously expressed markers 
utilized for MSC identification, more specific markers need to be discovered. In our study, Tgfbr2 and 
Anxa1 characterize cluster 2 PV-ADSCs specifically and bears the potential to identify this population 
homogenously in vivo. However, because of the limited number of primary PV-ADSCs, only a small 
number of cells were sequenced in our study. This is one limitation of the study. Sequencing of more 
primary cells would provide the possibility to discover better identity markers unique for MSC 
population or sub-population. Another limitation of the study mainly lies in the lack of in vivo 
evidence for PV-ADSC contribution to vascular injury repair. Future investigation of in vivo PV-
ADSC fate labeled by markers found by this study and future scRNA-seq data with larger cell number 
are needed. 
      Under disease settings such as atherosclerosis and vascular injury, adventitia stem cells migrate to 
the injury site and differentiate towards vascular lineages in response to the cytokine profile 
changes.50, 51 Similar explorations of PV-ADSC responses in diseased status would provide novel 
therapeutic insights. Cell transplantation experiments of RFP-labeled PV-ADSCs in vein graft 
transplantation experiments confirmed their involvement in vascular remodeling, similar to adventitia 
stem cells. Preliminary result demonstrating the migration of PV-ADSCs towards chemoattractant 
SDF-1 suggests that cell migration is among the complex mechanisms through which PV-ADSCs 
participate in vascular injury repair, and thus is a potentially interesting field. These findings together 
expand the pool of the resident vascular stem cell population consisting adventitia stem cells to 
include MSCs that reside in the PVAT. Lineage tracing studies with markers identified by scRNA-seq 
are in need to further assess the in vivo physiological and pathophysiological role of PV-ADSCs.  
      Regarding the differentiation mechanism, accumulating evidence has demonstrated the 
importance of metabolic reprogramming in stem cell differentiation.11, 44 It was shown that increased 
glycolysis is associated with pluripotency and increased mitochondrial respiration is associated with 
differentiation in pluripotent stem cells.52 MSCs displayed suppressed glycolysis when driven to 
differentiation towards osteocytes.53 Our study characterized the metabolic profile change of PV-
ADSCs during SMC differentiation and proposed the importance of lipid metabolism in regulating the 
differentiation process. MiR-378-3a bears potential in regulating SMC differentiation. Efforts are 
needed to further validate the function of miR-378-3a in vascular injury models and explore its 
therapeutic potential. 
     Evidence of the important role of the adipose-vascular crosstalk in various metabolic diseases has 
identified novel targets such as perivascular relaxing factors54 or secreted adipokines55 with significant 
therapeutic potential. By demonstrating the role of PV-ADSCs in vascular remodeling through 
metabolism-related regulation of SMC differentiation, our results support the need to further 
investigate the role of PV-ADSCs in vascular remodeling in various metabolic diseases such as 
atherosclerosis and diabetes mellitus. The process of PV-ADSC-involved vascular remodeling, which 
was not recognized before, might be targeted in future therapeutic development for metabolic diseases. 
Potential future exploration also includes the influence of adipokines secreted by perivascular adipose 
tissue on PV-ADSC differentiation and function, especially under disease conditions, given that 
preliminary results have shown the promoting effect of IGFBP-2 on SMC differentiation. Collectively, 
our study provides direct evidence of PV-ADSC heterogeneity through high-resolution 
characterization with scRNA-seq and suggests their participation in vascular remodeling through 
SMC differentiation driven by metabolic reprogramming which necessitate confirmation with further 
in vivo lineage tracing experiments. Taken together, the results imply the previously unappreciated 
identity and function of PV-ADSCs in vascular remodeling, unveil the mechanism for SMC 
differentiation from a metabolic perspective and provide insights for future studies to investigate the 
role of PV-ADSCs in various metabolic diseases. 
 
Fo
r A
TV
B 
Pe
er 
Re
vie
w.
 D
o n
ot 
dis
tri
bu
te.
 D
es
tro
y
    
    
    
    
    
    
    
    
  a
fte
r u
se
.
14 
 
Acknowledgments 
The authors acknowledge financial support from the Department of Health via the National Institute 
for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s & St 
Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College 
Hospital NHS Foundation Trust. NMR experiments were produced using the facilities of the Centre 
for Biomolecular Spectroscopy, King’s College London, acquired with a Multi-user Equipment Grant 
from the Wellcome Trust and an Infrastructure Grant from the British Heart Foundation. Breeding of 
miR-378a knockout mice was supported by the MAESTRO and OPUS grants of the Polish National 
Science Center [2012/06/A/NZ1/0004, 2012/07/B/NZ1/02881] to J.Du.  
 
Sources of Funding 
This work is supported by the British Heart Foundation (RG/14/6/31144). 
 
Disclosures 
None. 
 
References 
1. Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL. Crosstalk 
between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol. 2010;10:191-
196. 
2. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL. Proinflammatory phenotype of 
perivascular adipocytes. Arterioscler Thromb Vasc Biol. 2014;34:1631-1636. 
3. Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C, Zhang J, Wu J, Zeng R, Chen YE. Loss of 
perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion 
in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. 
Circulation. 2012;126:1067-1078. 
4. Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R, Bogdanov VY, Tang Y, 
Blomkalns AL, Hui DY, Weintraub NL. Transplanted perivascular adipose tissue accelerates 
injury-induced neointimal hyperplasia: Role of monocyte chemoattractant protein-1. 
Arterioscler Thromb Vasc Biol. 2014;34:1723-1730. 
5. Barker N, Bartfeld S, Clevers H. Tissue-resident adult stem cell populations of rapidly self-
renewing organs. Cell Stem Cell. 2010;7:656-670. 
6. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in 
the adventitia contribute to atherosclerosis of vein grafts in apoe-deficient mice. J Clin Invest. 
2004;113:1258-1265. 
7. Zhang L, Issa Bhaloo S, Chen T, Zhou B, Xu Q. Role of resident stem cells in vessel formation 
and arteriosclerosis. Circ Res. 2018;122:1608-1624. 
8. Lin G, Garcia M, Ning H, Banie L, Guo YL, Lue TF, Lin CS. Defining stem and progenitor cells 
within adipose tissue. Stem Cells Dev. 2008;17:1053-1063. 
9. Fraser JK, Schreiber R, Strem B, Zhu M, Alfonso Z, Wulur I, Hedrick MH. Plasticity of human 
adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc 
Med. 2006;3 Suppl 1:S33-37. 
10. Wilson NK, Kent DG, Buettner F, et al. Combined single-cell functional and gene expression 
analysis resolves heterogeneity within stem cell populations. Cell Stem Cell. 2015;16:712-724. 
11. Gu W, Gaeta X, Sahakyan A, Chan AB, Hong CS, Kim R, Braas D, Plath K, Lowry WE, Christofk 
HR. Glycolytic metabolism plays a functional role in regulating human pluripotent stem cell 
state. Cell Stem Cell. 2016;19:476-490. 
Fo
r A
TV
B 
Pe
er 
Re
vie
w.
 D
o n
ot 
dis
tri
bu
te.
 D
es
tro
y
    
    
    
    
    
    
    
    
  a
fte
r u
se
.
15 
 
12. Ito K, Carracedo A, Weiss D, Arai F, Ala U, Avigan DE, Schafer ZT, Evans RM, Suda T, Lee CH, 
Pandolfi PP. A pml-ppar-delta pathway for fatty acid oxidation regulates hematopoietic stem 
cell maintenance. Nat Med. 2012;18:1350-1358. 
13. Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of rna-
seq experiments with hisat, stringtie and ballgown. Nat Protoc. 2016;11:1650-1667. 
14. Buettner F, Natarajan KN, Casale FP, Proserpio V, Scialdone A, Theis FJ, Teichmann SA, 
Marioni JC, Stegle O. Computational analysis of cell-to-cell heterogeneity in single-cell rna-
sequencing data reveals hidden subpopulations of cells. Nat Biotechnol. 2015;33:155-160. 
15. Gardeux V, David FPA, Shajkofci A, Schwalie PC, Deplancke B. Asap: A web-based platform 
for the analysis and interactive visualization of single-cell rna-seq data. Bioinformatics. 
2017;33:3123-3125. 
16. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. David: Database 
for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3. 
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, 
Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-
based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 
2005;102:15545-15550. 
18. Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic 
data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411-420. 
19. Merrick D, Sakers A, Irgebay Z, Okada C, Calvert C, Morley MP, Percec I, Seale P. 
Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science. 
2019;364 
20. Schwalie PC, Dong H, Zachara M, Russeil J, Alpern D, Akchiche N, Caprara C, Sun W, 
Schlaudraff KU, Soldati G, Wolfrum C, Deplancke B. A stromal cell population that inhibits 
adipogenesis in mammalian fat depots. Nature. 2018;559:103-108. 
21. Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, 
Mikkelsen TS, Rinn JL. The dynamics and regulators of cell fate decisions are revealed by 
pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381-386. 
22. Kanamori M, Konno H, Osato N, Kawai J, Hayashizaki Y, Suzuki H. A genome-wide and 
nonredundant mouse transcription factor database. Biochem Biophys Res Commun. 
2004;322:787-793. 
23. Beronja S, Livshits G, Williams S, Fuchs E. Rapid functional dissection of genetic networks via 
tissue-specific transduction and rnai in mouse embryos. Nat Med. 2010;16:821-827. 
24. Le Bras A, Yu B, Issa Bhaloo S, Hong X, Zhang Z, Hu Y, Xu Q. Adventitial sca1+ cells transduced 
with etv2 are committed to the endothelial fate and improve vascular remodeling after 
injury. Arterioscler Thromb Vasc Biol. 2018;38:232-244. 
25. Gu W, Hong X, Le Bras A, Nowak WN, Issa Bhaloo S, Deng J, Xie Y, Hu Y, Ruan XZ, Xu Q. 
Smooth muscle cells differentiated from mesenchymal stem cells are regulated by micrornas 
and suitable for vascular tissue grafts. J Biol Chem. 2018;293:8089-8102. 
26. Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein 
graft atherosclerosis, which is diminished in apoe-deficient mice. Circ Res. 2003;93:e76-86. 
27. Kozlowska J, Rivett DW, Vermeer LS, Carroll MP, Bruce KD, Mason AJ, Rogers GB. A 
relationship between pseudomonal growth behaviour and cystic fibrosis patient lung 
function identified in a metabolomic investigation. Metabolomics. 2013;9 
28. Sellick CA, Croxford AS, Maqsood AR, Stephens G, Westerhoff HV, Goodacre R, Dickson AJ. 
Metabolite profiling of recombinant cho cells: Designing tailored feeding regimes that 
enhance recombinant antibody production. Biotechnol Bioeng. 2011;108:3025-3031. 
29. Worley B, Powers R. Multivariate analysis in metabolomics. Curr Metabolomics. 2013;1:92-
107. 
30. Xia J, Sinelnikov IV, Han B, Wishart DS. Metaboanalyst 3.0--making metabolomics more 
meaningful. Nucleic Acids Res. 2015;43:W251-257. 
Fo
r A
TV
B 
Pe
er 
Re
vie
w.
 D
o n
ot 
dis
tri
bu
te.
 D
es
tro
y
    
    
    
    
    
    
    
    
  a
fte
r u
se
.
16 
 
31. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in 
multiple human organs. Cell Stem Cell. 2008;3:301-313. 
32. Tabatabaei Qomi R, Sheykhhasan M. Adipose-derived stromal cell in regenerative medicine: 
A review. World J Stem Cells. 2017;9:107-117. 
33. Stzepourginski I, Nigro G, Jacob JM, Dulauroy S, Sansonetti PJ, Eberl G, Peduto L. Cd34+ 
mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis 
and after injury. Proc Natl Acad Sci U S A. 2017;114:E506-E513. 
34. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, 
Krause DS, Keating A, International Society for Cellular T. Clarification of the nomenclature 
for msc: The international society for cellular therapy position statement. Cytotherapy. 
2005;7:393-395. 
35. Chen Y, Wong MM, Campagnolo P, Simpson R, Winkler B, Margariti A, Hu Y, Xu Q. 
Adventitial stem cells in vein grafts display multilineage potential that contributes to 
neointimal formation. Arterioscler Thromb Vasc Biol. 2013;33:1844-1851. 
36. Houlihan DD, Mabuchi Y, Morikawa S, Niibe K, Araki D, Suzuki S, Okano H, Matsuzaki Y. 
Isolation of mouse mesenchymal stem cells on the basis of expression of sca-1 and pdgfr-
alpha. Nat Protoc. 2012;7:2103-2111. 
37. Guimaraes-Camboa N, Cattaneo P, Sun Y, Moore-Morris T, Gu Y, Dalton ND, Rockenstein E, 
Masliah E, Peterson KL, Stallcup WB, Chen J, Evans SM. Pericytes of multiple organs do not 
behave as mesenchymal stem cells in vivo. Cell Stem Cell. 2017;20:345-359 e345. 
38. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and 
adult fibroblast cultures by defined factors. Cell. 2006;126:663-676. 
39. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: Genetics, lipid uptake, and regulation. J 
Lipid Res. 2002;43:1997-2006. 
40. Ji C, Liu X, Xu L, Yu T, Dong C, Luo J. Runx1 plays an important role in mediating bmp9-
induced osteogenic differentiation of mesenchymal stem cells line c3h10t1/2, murine multi-
lineage cells lines c2c12 and mefs. Int J Mol Sci. 2017;18 
41. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: 
Pathological and therapeutic implications. Nat Immunol. 2014;15:1009-1016. 
42. Gu W, Ni Z, Tan YQ, Deng J, Zhang SJ, Lv ZC, Wang XJ, Chen T, Zhang Z, Hu Y, Jing ZC, Xu Q. 
Adventitial cell atlas of wt (wild type) and apoe (apolipoprotein e)-deficient mice defined by 
single-cell rna sequencing. Arterioscler Thromb Vasc Biol. 2019;39:1055-1071. 
43. Villarroya F, Cereijo R, Villarroya J, Giralt M. Brown adipose tissue as a secretory organ. Nat 
Rev Endocrinol. 2017;13:26-35. 
44. Chandel NS, Jasper H, Ho TT, Passegue E. Metabolic regulation of stem cell function in tissue 
homeostasis and organismal ageing. Nat Cell Biol. 2016;18:823-832. 
45. Goldberg EL, Dixit VD. Carnitine acetyltransferase (crat) expression in macrophages is 
dispensable for nutrient stress sensing and inflammation. Mol Metab. 2017;6:219-225. 
46. Krist B, Florczyk U, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J. The role of mir-378a in 
metabolism, angiogenesis, and muscle biology. Int J Endocrinol. 2015;2015:281756. 
47. Pevsner-Fischer M, Levin S, Zipori D. The origins of mesenchymal stromal cell heterogeneity. 
Stem Cell Rev. 2011;7:560-568. 
48. Gu W, Hong X, Potter C, Qu A, Xu Q. Mesenchymal stem cells and vascular regeneration. 
Microcirculation. 2017;24 
49. Hardy WR, Moldovan NI, Moldovan L, Livak KJ, Datta K, Goswami C, Corselli M, Traktuev DO, 
Murray IR, Peault B, March K. Transcriptional networks in single perivascular cells sorted 
from human adipose tissue reveal a hierarchy of mesenchymal stem cells. Stem Cells. 
2017;35:1273-1289. 
50. Xie Y, Potter CMF, Le Bras A, Nowak WN, Gu W, Bhaloo SI, Zhang Z, Hu Y, Zhang L, Xu Q. 
Leptin induces sca-1(+) progenitor cell migration enhancing neointimal lesions in vessel-
injury mouse models. Arterioscler Thromb Vasc Biol. 2017;37:2114-2127. 
Fo
r A
TV
B 
Pe
er 
Re
vie
w.
 D
o n
ot 
dis
tri
bu
te.
 D
es
tro
y
    
    
    
    
    
    
    
    
  a
fte
r u
se
.
17 
 
51. Yu B, Kiechl S, Qi D, et al. A cytokine-like protein dickkopf-related protein 3 is 
atheroprotective. Circulation. 2017;136:1022-1036. 
52. Xu X, Duan S, Yi F, Ocampo A, Liu GH, Izpisua Belmonte JC. Mitochondrial regulation in 
pluripotent stem cells. Cell Metab. 2013;18:325-332. 
53. Daud H, Browne S, Al-Majmaie R, Murphy W, Al-Rubeai M. Metabolic profiling of 
hematopoietic stem and progenitor cells during proliferation and differentiation into red 
blood cells. N Biotechnol. 2016;33:179-186. 
54. Gollasch M. Adipose-vascular coupling and potential therapeutics. Annu Rev Pharmacol 
Toxicol. 2017;57:417-436. 
55. Akoumianakis I, Tarun A, Antoniades C. Perivascular adipose tissue as a regulator of vascular 
disease pathogenesis: Identifying novel therapeutic targets. Br J Pharmacol. 2017;174:3411-
3424. 
  
 
Highlights 
 
? Single-cell RNA sequencing allows direct visualization of PV-ADSC heterogeneity at a single-
cell level and uncovers two sub-populations with distinct signature genes and signaling pathways.  
? The function of PVAT in vascular regeneration are partly attributed to PV-ADSCs and their 
differentiation towards smooth muscle lineage.  
? TGFb1 and miR-378a-3p mimics induced a similar metabolic reprogramming of PV-ADSCs, 
including upregulated mitochondrial potential and altered lipid levels such as increased 
cholesterol and promoted smooth muscle differentiation. 
 
 
Figure Legends 
Figure 1. Characterization of PV-ADSCs. A and B, Representative histograms of flow cytometry 
analysis of cultured PV-ADSCs and the percentage of indicated phenotypic markers (n=3). Gating is 
set for the IgG control to be between 0.5% to 1%. C, Immunofluorescent staining of the adipose tissue 
surrounding the mouse aorta with CD29, Sca1, PECAM1, PLIN1 and DAPI (n=3). Arrows indicate 
the CD29+/Sca1+/PECAM1-/PLIN1- cells. The border between End (endothelium), Med (media), Adv 
(adventitia) and PVAT (perivascular adipose tissue) is drawn with dashed line. Scale bar, 50 μm. Ctrl 
indicates IgG isotype control; DAPI, 4′,6-diamidino-2-phenylindole; and PV-ADSCs, perivascular 
adipose tissue-derived mes nchymal stem cells. 
Figure 2. ScRNA-seq reveals two distinct clusters in PV-ADSCs. A, Sorting gate for scRNA-seq 
was set as live nucleated cells (Syto16+/DAPI-), single cells, CD45-/CDH5- cells and CD29+/Sca1+ 
cells. B, Scatter plot obtained from MDS analysis showed two distinct clusters. Color scale, log2(gene 
counts). C, Expression of representative genes for cluster 1 (Cd36) and cluster 2 (Tgfbr2). D, 
Heatmap of marker genes in each cluster. Color scale, log2(gene counts). Full list of genes was in 
Table I in the online-only Data Supplement. E and F, Gene ontology and KEGG pathway analysis of 
the top 200 genes (by P value) upregulated in Cluster 1 (E) and Cluster 2 (F). Full list of GO terms 
and KEGG pathways was in Table II in the online-only Data Supplement. G, Enrichment of gene sets 
including Myogenesis (Molecular Signature) and TGF-b signaling (KEGG). H, Expression heatmap 
of frequently-used MSC markers. Color scale, log2(gene counts). I, Expression of frequently-used 
MSC markers in the two clusters was shown as violin plot. Cl 1 indicates cluster 1; Cl 2, cluster 2; 
FDR, false discovery rate; GOMF, gene ontology molecular function; KEGG, Kyoto encyclopedia of 
genes and genomes; and NES, normalized enrichment score.  
Figure 3. Pseudotime trajectory of cultured PV-ADSCs. A, Cell stages expressing early to late 
SMC markers. B, Pseudotime trajectory of cultured PV-ADSCs with “DDRTree” method for 
dimension reduction. Color scale, pseudotime. C, Cell ordering from different differentiation stages 
along the pseudotime trajectory. D, Heatmap of the top 1000 (by q value) significantly changed genes 
in three gene modules. E, Expression of Ly6a, Cnn1 and Myh11 along the trajectory. Color scale, log 
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gene expression. F, Gene ontology (molecular function) analysis of each gene module from (D). Full 
list was in Table III in the online-only Data Supplement. G, Expression of significantly changed genes 
from TGF-b signaling pathway (KEGG) along pseudotime. Full list was in Table I in the online-only 
Data Supplement. Color scale, log gene expression. H, Tgfb2 expression and total level of 
significantly changed genes from TGF-b signaling along the pseudotime trajectory. Color scale, log 
gene expression. I, Expression of significantly changed transcription factors along the pseudotime 
trajectory. Full list was in Table I in the online-only Data Supplement. Color scale, log gene 
expression.  
Figure 4. PV-ADSCs differentiate towards SMCs in vivo and in vitro. A, H&E staining of the vein 
graft harvested 4 weeks after the transplantation. Neointimal area was calculated against injury-only 
control (n=4). Arrow indicates the boundary between neo-intima and media layer. B, Vein grafts 
harvested one week after the transplantation were stained with RFP (red) and SMC marker ACTA2 
(green) (n=4). Arrows indicate cells positive for both markers. Dashed line indicates boundary of 
adventitia and neointima. Scale bar, 20 μm. C-E, In vitro cultured PV-ADSCs were differentiated 
towards SMCs in differentiation medium for 5 days (diff) and then harvested for Q-PCR (C) (n=4), 
Western blot (D) (n=3) and immunofluorescent staining (E) (n=3) for SMC markers. Cells cultured 
without TGFb1 (ctrl) served as control. Scale bar, 20 μm. F, Chemotaxis of PV-ADSCs in response to 
an increasing gradient of SDF1 in an 8.0-μm transwell system was identified by applying 1% crystal 
violet staining after 16-h incubation (n=3). Scale bar, 50 μm. G, H&E staining of subcutaneous 
Matrigel plug containing PV-ADSCs-derived SMCs and ECs (diff) in comparison with control group 
(ctrl) (n=4). H, Immunostaining of the tube-like structure in Matrigel plug with ACTA2 and 
PECAM1 (n=4). Scale bar, 50 μm. Data are presented as mean±SD. *P<0.05, **P<0.01. Adv 
indicates adventitia. 
Figure 5. Metabolic reprogramming of PV-ADSCs during SMC differentiation. A and B, 
Cellular metabolite abundance was detected with NMR system in undifferentiated PV-ADSCs and 
PV-ADSCs differentiated for 1 day (n=8). A, Heatmap for metabolite levels. B, Orthogonal projection 
to latent structures. C, The OCR measured in PV-ADSCs cultured with or without TGFb1 for 1 day 
(n=3). D, Live PV-ADSCs cultured in differentiation medium or basal growth medium for 1 day and 
4 days were stained TMRM to detect mitochondrial potential (n=3). E and F, Cellular metabolite 
abundance in undifferentiated PV-ADSCs or PV-ADSCs differentiated for 4 days was determined 
with GC-MS system (n=3). Heatmaps of met bolites involved in TCA cycle (E) or lipid metabolism 
(F) were shown. G, Gene expression of genes important in lipid metabolism in PV-ADSCs treated 
with or without TGFb1 for 2 days (n=4). H, Expression of Cebpb along the pseudotime trajectory. 
Color scale, log expression of gene. I, Crat mRNA level in PV-ADSCs treated with or without 
TGFb1 for 2 days (n=4). Data are presented as mean±SD. *P<0.05, **P<0.01 and ***P<0.001. Anti-
A/Rot indicates anti-mycin A/Rotenone; FCCP, carbonyl cyanide-4-phenylhydrazone; MFI, mean 
fluorescence intensity; OCR, oxygen consumption rate; Oligo, oligomycin; SRC, spare respiratory 
consumption; and TMRM, Tetramethylrhodamine, Methyl Ester, Perchlorate.  
Figure 6. Crat knockdown promotes SMC differentiation via upregulation of TGFb1. A-C, PV-
ADSCs treated with Crat siRNA with or without TGFb1 for two days. A, Crat level was significantly 
downregulated after siRNA Crat transfection. Q-PCR also showed the induction of SMC markers 
(Cnn1, Tagln and Acta2) with Crat knockdown. B, Protein level induction of SMC markers by Crat 
siRNA was demonstrated by Western blot. C, Immunostaining and statistical analysis showed the 
induction of SMC markers by Crat siRNA in medium without TGFb1. D-F, TGFb1 level after Crat 
siRNA transfection for 2 days was determined with Q-PCR (D), Western blot (E) and 
immunofluorescent staining (F). Results are cumulative (A and D) or representative (B, C, E and F) of 
three independent experiments. Scale bar, 30 μm. Data are presented as mean±SD. *P<0.05, 
**P<0.01 and ***P<0.001. 
Figure 7. miR-378a-3p induces metabolic reprogramming and promotes SMC differentiation. A, 
The OCR of PV-ADSCs cultured in miR-378a-3p mimics or control for 2 days (n=3). B, Live PV-
ADSCs treated with miR-378a-3p mimic for 2 days with or without TGFb1 were stained TMRM and 
analyzed for MFI with flow cytometry (n=3). C and D, Cellular metabolite abundance in PV-ADSCs 
treated with miR-378a-3p mimics for 1 day determined with GC-MS system (n=3). Heatmap of 
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metabolites in TCA cycle (C) or lipid metabolism (D). E, SMC marker mRNAs were induced by 
miR-378a-3p mimics after 2 days (n=3). F, Representative immunofluorescent staining (n=3) showed 
the upregulation of SMC markers by miR-378a-3p mimic treatment. G, Transfection of PV-ADSCs 
with miR-378a-3p inhibitor inhibited the level of SMC markers as shown by Q-PCR. The level of 
Crat was de-repressed by miR-378a-3p inhibitor transfection (n=3). H, OCR and ECAR were 
detected with Seahorse Mito stress tests in wild-type (WT) and miR-378a knockout (KO) ADSCs 
(n=3). I, Wild-type (WT) and miR-378a knockout (KO) ADSCs were treated with or without TGFb1 
for 2 days. Immunofluorescent staining showed the protein level of CNN1 (n=1). Scale bar, 100 μm. 
Data are mean±SD. *P<0.05 and **P<0.01. Anti-A/Rot indicates anti-mycin A/Rotenone;  Crat, 
carnitine acetyltransferase; FCCP, carbonyl cyanide-4-phenylhydrazone; inh 378, miR-378a-3p 
inhibitor; inh ctrl, inhibitor control; MFI, mean fluorescence intensity; mim 378, miR-378a-3p mimics; 
mim ctrl, mimics control; OCR, oxygen consumption rate; oligo, oligomycin; SRC, spare respiratory 
capacity; and TMRM, Tetramethylrhodamine, Methyl Ester, Perchlorate. 
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